Pathology of the lesion compatible with poorly differentiated carcinoma and liver metastases was metastatic adenocarcinoma. Material from the colon biopsy and liver lesions were sent for ...

Ultrasensitive ctDNA assay could detect post-surgery colorectal cancer recurrence well before imaging-based detection of clinical relapse, according to results presented by Emma Titmuss, MSc, at ...

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value.

Dataset B, the colon polyp biopsy dataset, included 100 cases composed of five categories: hyperplastic polyp (HP), sessile serrated adenoma (SSA), tubular adenoma with low-grade dysplasia (TA), ...

20 things you probably don’t know about colon cancer But if you are 45 or older, you should really worry about colon cancer because there are many facts you probably don’t know about it. Your ...

On biopsy, this tumor was found to have both adenocarcinoma and neuroendocrine components. There was evidence of synaptophysin expression in the neuroendocrine component, but none in the ...

The FDA approved a blood test intended to detect colon cancer, which many experts hope will help catch cases of the disease early enough so that they can be more easily treated.

Performance of a tumor-informed molecular residual disease (MRD) assay in resected bladder cancer with mixed or pure variant histology: Analysis of a real-world multicenter cohort. Impact of squamous ...

SAN FRANCISCO -- In separate studies, liquid biopsy produced mixed results for guiding colon cancer treatment. Adjuvant chemotherapy guided by postoperative circulating tumor (ct) DNA did not lead ...

Histopathologic features are critical for studying risk factors of colorectal polyps, but remain deeply embedded within unstructured pathology reports, requiring costly and time-consuming manual ...

Now, a team at Harvard Medical School has combined histology with cutting-edge single-cell imaging technologies to create large-scale 2D and 3D spatial maps of colorectal cancer.

Liquid biopsy study suggests a better way to decide which colorectal cancer patients need chemo By Jonathan Wosen Reprints Gillian Flaccus/AP ...